Literature DB >> 7862459

p53 phosphorylation mutants retain transcription activity.

B Fuchs1, D O'Connor, L Fallis, K H Scheidtmann, X Lu.   

Abstract

To investigate the effect of phosphorylation on the transcription activity of p53, ten phosphorylation mutants were constructed covering all the identified phosphorylation sites of rat p53. These included mutants of two casein kinase I sites (Ser6 and Ser9), two DNA-PK sites (Ser15 and Ser39), a p34cdc2 site (Ser313), the adjacent Ser312 and a casein kinase II site (Ser390). Two double phosphorylation mutants (Ser4, 6 and Ser15, 390) and one triple phosphorylation mutant (Ser4, 6 and 15) were also constructed. The transcription activity of all the p53 phosphorylation mutants was tested by transfection into two different types of cells, Saos-2 cells and p53(-/-) fibroblasts derived from p53 knock out mice, which both lack endogenouse p53. Surprisingly, all the p53 phosphorylation mutants retain transcription activity and the seven mutants tested can also suppress cell growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862459

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.

Authors:  M D Kaeser; R D Iggo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.

Authors:  H Hayashi; H Miyamoto; T Ito; Y Kameda; N Nakamura; Y Kubota; H Kitamura
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

4.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

5.  Kinetics of p53 binding to promoter sites in vivo.

Authors:  S T Szak; D Mays; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  Conformation-dependent phosphorylation of p53.

Authors:  V Adler; M R Pincus; T Minamoto; S Y Fuchs; M J Bluth; P W Brandt-Rauf; F K Friedman; R C Robinson; J M Chen; X W Wang; C C Harris; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 7.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

8.  Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation.

Authors:  M Kapoor; G Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

9.  Regulation of p53 function and stability by phosphorylation.

Authors:  M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

10.  Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation.

Authors:  S R Hall; L E Campbell; D W Meek
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.